280 related articles for article (PubMed ID: 9350236)
1. [Lung cancer].
Furuse K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236
[TBL] [Abstract][Full Text] [Related]
2. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
Mavroudis D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
[No Abstract] [Full Text] [Related]
3. [Developed new agents for lung cancer].
Kato Y; Saijo N
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
[TBL] [Abstract][Full Text] [Related]
4. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
Rigas JR
Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in metastatic non-small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
[TBL] [Abstract][Full Text] [Related]
6. New chemotherapeutic agents for non-small cell lung cancer.
Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
[TBL] [Abstract][Full Text] [Related]
7. [Current perspectives of new agents in lung cancer].
Fukuoka M
Nihon Rinsho; 2000 May; 58(5):1103-10. PubMed ID: 10824557
[TBL] [Abstract][Full Text] [Related]
8. [Gemcitabine].
Takeda K
Nihon Rinsho; 2002 May; 60 Suppl 5():359-65. PubMed ID: 12101689
[No Abstract] [Full Text] [Related]
9. [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].
Morere JF
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S37-41. PubMed ID: 11924242
[No Abstract] [Full Text] [Related]
10. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
Tumolo S; Toffoli G; Saracchini S; Lo Re G; Bruschi G; Boccieri MG
Lung Cancer; 2001 Dec; 34 Suppl 4():S37-46. PubMed ID: 11742701
[TBL] [Abstract][Full Text] [Related]
11. Promising new agents in the treatment of non-small cell lung cancer.
Edelman MJ; Gandara DR
Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
Calvo AR; Belani CP
Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988
[No Abstract] [Full Text] [Related]
13. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
14. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
Meert AP; Berghmans T; Branle F; Lemaître F; Mascaux C; Rubesova E; Vermylen P; Paesmans M; Sculier JP
Anticancer Res; 1999; 19(5C):4379-90. PubMed ID: 10650780
[TBL] [Abstract][Full Text] [Related]
15. [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].
Grossi F; de Marinis F; Frontini L; Gridelli C
Tumori; 2008; 94(3):5-14. PubMed ID: 18705422
[No Abstract] [Full Text] [Related]
16. Rationale for non-platinum chemotherapy in advanced NSCLC.
Murren JR
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiation in locally advanced non-small cell lung cancer.
Bonomi P; Shirazi W
Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
[No Abstract] [Full Text] [Related]
20. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Bunn PA; Kelly K
Clin Cancer Res; 1998 May; 4(5):1087-100. PubMed ID: 9607565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
